Lipodystrophy: Time for a global registry and randomized clinical trials to assess efficacy, safety and cost-effectiveness of established and novel medications-Reference-Cited by-同舟云学术

Lipodystrophy: Time for a global registry and randomized clinical trials to assess efficacy, safety and cost-effectiveness of established and novel medications

Published:2017-07 Issue: Volume:72 Page:A4-A10
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Polyzos Stergios A.,Mantzoros Christos S.

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference44 articles.

1. Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals;Moon;Endocr Rev,2013

2. Leptin in congenital or HIV-associated lipodystrophy and metabolic syndrome: A need for more mechanistic studies and large, randomized, placebo-controlled trials;Foo;Metabolism,2012

3. Clinical review#: Lipodystrophies: genetic and acquired body fat disorders;Garg;J Clin Endocrinol Metab,2011

4. Lipodystrophy Syndromes;Tsoukas,2016

5. Lipodystrophic syndromes;Mantzoros,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Familial Screening for the Prevention of Rare Diseases: A Focus on Lipodystrophy in Southern Saudi Arabia;Journal of Epidemiology and Global Health;2024-01-17

2. Adiponectin, Diabetes, and the Cardiovascular System;Diabetes and Cardiovascular Disease;2023

3. When Sugar Reaches the Liver: Phenotypes of Patients with Diabetes and NAFLD;Journal of Clinical Medicine;2022-06-08

4. Efficacy and Cardiovascular Safety of Thiazolidinediones;Current Drug Safety;2021-06-08

5. Lipodystrophies—Disorders of the Fatty Tissue;International Journal of Molecular Sciences;2020-11-20